Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel as adjunctive therapy in refractory partial seizures
NCT00700310Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Aug 2008
- Primary completion
- Aug 2009
- Modality
- Classical Binding Small Molecules
- Countries
- 23
01
Overview
A Phase 3 trial of perampanel in focal seizures, sponsored by Eisai Co., Ltd.. Started Aug 2008; status: completed.
02
Drugs
perampanel
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00700310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700310.